BioCardias CardiAMP Cell Therapy Trial Faces Setback but Remains Committed to Advancing Regenerative Medicine
On September 5, 2023, BioCardia, a cutting-edge company specializing in regenerative medicine, unveiled the latest findings from the phase III ...